Macquarie Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-146,347
| Closed | -$7.68M | – | 2412 |
|
|
2020
Q3 | $7.68M | Sell |
146,347
-47,036
| -24% | -$1.95M | 0.01% | 715 |
|
|
2020
Q2 | $6.43M | Buy |
193,383
+571
| +0.3% | +$18.2K | 0.01% | 737 |
|
|
2020
Q1 | $5.24M | Sell |
192,812
-25,949
| -12% | -$722K | 0.01% | 703 |
|
|
2019
Q4 | $4.32M | Sell |
218,761
-4,694
| -2% | -$75.1K | 0.01% | 841 |
|
|
2019
Q3 | $2.9M | Buy |
223,455
+4,738
| +2% | +$57.2K | ﹤0.01% | 914 |
|
|
2019
Q2 | $2.72M | Buy |
218,717
+77,216
| +55% | +$1.03M | ﹤0.01% | 939 |
|
|
2019
Q1 | $2.06M | Hold |
141,501
| – | – | ﹤0.01% | 984 |
|
|
2018
Q4 | $1.56M | Buy |
141,501
+28,501
| +25% | +$397K | ﹤0.01% | 1021 |
|
|
2018
Q3 | $2.97M | Hold |
113,000
| – | – | ﹤0.01% | 899 |
|
|
2018
Q2 | $2.31M | Hold |
113,000
| – | – | ﹤0.01% | 960 |
|
|
2018
Q1 | $2.05M | Buy |
113,000
+43,000
| +61% | +$717K | ﹤0.01% | 978 |
|
|
2017
Q4 | $977K | Sell |
70,000
-20,000
| -22% | -$270K | ﹤0.01% | 1251 |
|
|
2017
Q3 | $1.67M | Hold |
90,000
| – | – | ﹤0.01% | 1042 |
|
|
2017
Q2 | $1.52M | Hold |
90,000
| – | – | ﹤0.01% | 1044 |
|
|
2017
Q1 | $1.2M | Buy |
90,000
+10,000
| +13% | +$157K | ﹤0.01% | 1129 |
|
|
2016
Q4 | $1.2M | Hold |
80,000
| – | – | ﹤0.01% | 1112 |
|
|
2016
Q3 | $935K | Sell |
80,000
-80,000
| -50% | -$941K | ﹤0.01% | 1161 |
|
|
2016
Q2 | $1.73M | Buy |
160,000
+80,000
| +100% | +$825K | ﹤0.01% | 1176 |
|
|
2016
Q1 | $739K | Hold |
80,000
| – | – | ﹤0.01% | 1177 |
|
|
2015
Q4 | $1.19M | Hold |
80,000
| – | – | ﹤0.01% | 1050 |
|
|
2015
Q3 | $1.31M | Sell |
80,000
-55,000
| -41% | -$1.13M | ﹤0.01% | 1080 |
|
|
2015
Q2 | $3.08M | Hold |
135,000
| – | – | 0.01% | 906 |
|
|
2015
Q1 | $2.05M | Buy |
135,000
+25,000
| +23% | +$325K | ﹤0.01% | 1015 |
|
|
2014
Q4 | $1.32M | Buy |
110,000
+10,000
| +10% | +$114K | ﹤0.01% | 1110 |
|
|
2014
Q3 | $1.13M | Buy |
100,000
+10,000
| +11% | +$114K | ﹤0.01% | 1143 |
|
|
2014
Q2 | $1.09M | Buy |
90,000
+10,000
| +13% | +$118K | ﹤0.01% | 1185 |
|
|
2014
Q1 | $932K | Buy |
80,000
+30,000
| +60% | +$508K | ﹤0.01% | 1176 |
|
|
2013
Q4 | $884K | Hold |
50,000
| – | – | ﹤0.01% | 1177 |
|
|
2013
Q3 | $720K | Buy |
+50,000
| New | +$765K | ﹤0.01% | 1236 |
|
Macquarie Group's MNTA Position: Q4 2020 in Review
Macquarie Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 146,347 shares — an estimated $7.68M sold.
Macquarie Group first reported a position in MNTA in Q3 2013 and held it in 29 quarters. The position peaked at $7.68M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Macquarie Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Macquarie Group sold 146,347 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.68M.
- Macquarie Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 29 quarters.
- Macquarie Group's Momenta Pharmaceuticals, Inc. position peaked at $7.68M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.